FDA Investigator Rumany C Penn, PharmD

Rumany C Penn, PharmD has conducted inspections on 75 sites in 9 countries as of 14 Nov 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
75
Last Inspection Date:
14 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Ireland, China, Japan, United Kingdom of Great Britain and Northern Ireland, France, Korea (Republic of), South Africa, India
FDA Investigators that have inspected at least one site in common with Rumany C Penn, PharmD:
Alan P Kurtzberg, Alec M O'neal, Alex G Kalugin, Alexis R Ajello, Amalia C Himaya, Amanda N Schaupp, Amogh Pathi, Andrei Perlloni, Andrew B Slarve, Andrew E Kay, Angel K Sandhu, Angela D Wise, Anh M Lac, Anita Narula, PhD, Ankur C Patel, Ann Marie Montemurro, Anna L Marroquin, Anna L Viveros Hernandez, Arsen Karapetyan, Ashar P Parikh, Azza Talaat, Babajide Michael Osunsanmi, Barbara J Rincon, Benny Y Gong, Bichsa T Tran, Bijoy Panicker, Binh T Nguyen, Breena L D'ambrogi, Brent W Higgs, Brian J Ryan, Brian R Henderson, Brien C Fox, Bryan A Galvez, Capri R Woolridge, Carl Lee, Carla A Norris, Carla J Lundi, Carolina D Vasquez, Carrie A Hughes, Carrie E Thrasher, Caryn M Everly, Caryn M Mcnab, Cathleen A Carr Sharpe, CDR Rochelle B Young, RPh, MSA, Charles I Ann, Chelsea N Sealey, Cheryl A Clausen, Chloe Anne Leong, Christin L Torres, Christina A Miller, Christopher M Reed, Christopher T Middendorf, Cindy W Lewis, Claudia Mperez Kasmarski, Courtney R Bolton, Damon A Growl, Dandan Wang, PhD, Daniel C Geffin, Daniel J Roberts, Daniel Velasquez, Darren S Brown, David G Eng, Deborah K Richardson, Debra D Devlieger, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Dr. Jason R Caballero, Dustin P Tran, Dustin R Abaonza, Edna J Hidalgo, Eileen A Liu, Elaine S Chow, Elizabeth Juarez, Elodie X Tong Lin, Emal Wahab, Emmanuel O Kerry, Eric L Dong, BS, Eric M Mueller, PharmD, Erica R Mahone, Erica R Pomeroy, Erika V Butler, Estefania Fernandez, Farhana Khan, Felix Maldonado, Frank P Bianco, Garciam, Gerardo Z Vazquez, Gillenwater, Ginger M Sykes, Gwyn G Dickinson, Heidy C Perales, Helen J Hamaoka, Hung H Do, MS, Huy T Pham, Ismael Garibay, Jacqueline Mdiaz Albertini, Jacqueline O Snell, James A Lane, James C Lee, PharmD, Jamie L Dion, Jane G Choi, Jane S Wernberg, Janice R Small, Janice Wai, Jason F Chancey, Jawaid Hamid, Jeanmaire Hryshko, Jeffrey A Sommers, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer Crumb, Jennifer L Degroot, Jennifer L Huntington, Jennifer L Johnson, Jennifer Lalama, Jennifer M Gogley, Jennifer S King, Joan A Loreng, Joan T Briones, Joanne Hosting, Joanne M Fukuda, Joey V Quitania, John A Gonzalez, John A Liu, John Cook, Jolanna A Norton, Jorge L Bertran, Jorge L Guadalupe, José E Meléndez, Jose R Hernandez, Joseph A Piechocki, Joseph C Yen, Joseph M Willems, Joseph Tibay, Juanita Banuelos, Judy C Nepsa, Julie A Rorberg, Julie A Stocklin, Julie D Bringger, Justin A Boyd, Justin M Runac, Kacie M Crowther, Karen D Phung, Karen L Robles, Karen Takahashi, Karla J Gibler, Katherine Szestypalow, Kathy Chiu, Kathy Kuo, Kawshalya Pathiraja, Kejun Cheng, Kelley, Kellia N Hicks, Kenneth S Boehnen, Kent C Faul, Keren Arkin, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kimiko G Casuga, Kristin M Abaonza, Krystina M Jackson, Lance Mde Souza, MBA, Lata C Mathew, PhD, Lavender M Huskey, LCDR Jennifer H Rhyu, Lija V Fellows, Liming Zhang, Linda Thai, Ling Yu L Liu, Lisa H Nakagawa, Lisa L Flores, Lixia Cai, Lorraine N Williams, Lourdes Andujar, LT Mark A Chen, MPH, Lucila B Nwatu, Lydia S Chan, Lynn L Wong, Macropolk, Marcellinus D Dordunoo, Marcus F Yambot, Margaret M Annes, Maridali Deleon Torres, Marie F Morin, Marion W Nadeau, Marissa J Chan, Marjorie D Santos, Mark I Nakano, Mark R Mcclain, Mary C Wall, Mary E Storch, Matthew B Casale, Mcgrewp, Megan E Kulas, Meisha R Sampson, Meisha Waters, Michael D Garcia, Michael D Kawalek, Michael L Casner, Michael R Goga, Michael T Cyrus, Michelle L Tripp, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nathan R Moon, Nayan J Patel, Ngoc B Kelsch, Nicholas L Hunt, Nicole Yuen, Nympha V Florendo, Parul M Patel, Patrick C Klotzbuecher, Patrick E Gainer, Paula A Trost, Peter E Baker, Philip F Istafanos, DMV, MS, Phillip J Sample, Phung, Pratik S Upadhyay, DDC, Quynh H Strandberg, Raquel Gonzalez Rivera, Raymond Souweha, Raymond T Oji, Rebecca Rodriguez, Reginald D Neal, Richard C Chiang, Richmond K Yip, Robert C Coleman, Robert D Tollefsen, Robert L Stevenson, Robert M Barbosa, Roger D Gawne, Roger F Zabinski, Ronald P Boyce, Rose Ashley, Ross J Grigsby, Saied A Asbagh, Samina S Khan, Sammie P La, Sandra A Boyd, Sandra A Hughes, Santiago Gallardo Johnson, Satheesh Thomas, Scott N Lim, Scott T Ballard, Sean P Desbrow, Selene T Torres, Seyyida Saterfield, Sharon K Thoma, PharmD, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Siobhan A Gallagher, Sixto M Mercado Rios, Stacie A Woods, Stephanie A Slater, MS, Stephen R Souza, Steve P Yost, Steven P Donald, Steven R Gillenwater, Stuart Kim, Stuart W Russell, Sundy V Sedwick, Susan F Laska, MS, Tamala P Magee, Tamara L Ely, Tamil Arasu, PhD, Temar Q Williams, Teresa T Cain, Terrence Gee, Terri L Dodds, Thao T Kwan, Theresa Kirkham (NMI), Thomas J Arista, Thomas N Adjabeng, Thomas W Gordon, Tiara Nbrown Crosen, Tomanik'e C Banks, Torrance J Slayton, Toyin B Oladimeji, Tracey L Harris, Tracey T Duong, Travelle D Mason, Truong Xuan Nguyen (Andy), Trusten J Robles, Uduak M Inokon, Uttaniti Limchumroon (Tom), Vaishali J Patel, Vashti E Bocker, Vickie L Anderson, Victoria L Morgan, Vincent Thomas, Virgilio F Pacio, CSO, Walden H Lee, Wayne E Seifert, Wenzheng Wendy Zhang, William J Foust, William V Millar, Yasamin Ameri, Yen Tso Kuo, Youkeun Kim, Yvonne T Lacour, Zachary A Bogorad, Zachary L Miller, Zhongren Wu

Rumany C Penn, PharmD's Documents

Publish Date Document Type Title
March, 2018 FDA 483 MICRO CONNECTION ENTERPRISES, INC., THE - Form 483, 2018-03-06
July, 2018 FDA 483 Analytical Resource Labs - Form 483, 2018-07-20
December, 2019 FDA 483 Response Bachem Americas, Inc. - Form 483R, 2020-01-07
January, 2020 FDA 483 Nitto Avecia Pharma Services, Inc. - Form 483, 2020-01-24
February, 2020 FDA 483 Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy - Form 483, 2020-02-20
March, 2019 FDA 483 International Chemical Entity Japan Co.,Ltd. - Form 483, 2019-03-22
November, 2018 FDA 483 Advanced Botanical Consulting & Testing Inc - Form 483, 2018-11-13
October, 2018 FDA 483 Algunas Inc., dba Woodland Hills Compounding Pharmacy - Form 483, 2018-10-11
November, 2016 FDA 483 AMPAC Fine Chemicals LLC - Form 483, 2016-11-08
March, 2018 EIR Deseret Laboratories, Inc. - EIR, 2018-03-23
October, 2019 FDA 483 Catalent Nottingham Limited - Form 483, 2019-10-11
October, 2019 FDA 483 Allergan Pharmaceuticals Ireland - Form 483, 2019-10-25
March, 2019 FDA 483 Taisho Pharmaceutical Co., Ltd. - Form 483, 2019-03-29
January, 2019 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2019-01-15
July, 2017 FDA 483 One Way Drug, LLC - Form 483, 2017-07-19
March, 2020 FDA 483 TECHNICHEM CORP - Form 483, 2020-03-18
November, 2022 FDA 483 Eisai Co., Ltd. - Form 483, 2022-11-18
May, 2017 EIR CSBio Co. - EIR, 2017-05-12
May, 2016 FDA 483 Well Care Discount Pharmacy, LLC - Form 483, 2016-05-12
August, 2018 FDA 483 American Specialty Pharmacy - Form 483, 2018-08-23
March, 2019 FDA 483 Enprani Co., Ltd. - Form 483, 2019-03-15
January, 2019 FDA 483 Response INDOCO REMEDIES LIMITED - Form 483R, 2019-02-15
May, 2019 FDA 483 Strides Pharma Science Limited - Form 483, 2019-05-24
April, 2017 FDA 483 Response Validation Systems, Inc. - Form 483R, 2017-04-27
October, 2019 FDA 483 Charles River Laboratories Ireland Ltd. - Form 483, 2019-10-18
December, 2019 FDA 483 Bachem Americas, Inc. - Form 483, 2019-12-13
September, 2018 FDA 483 ASCLEMED USA INC. DBA ENOVACHEM - Form 483, 2018-09-27
April, 2017 FDA 483 Validation Systems, Inc. - Form 483, 2017-04-13
December, 2019 EIR Bachem Americas, Inc. - EIR, 2019-12-13
January, 2019 EIR INDOCO REMEDIES LIMITED - EIR, 2019-01-25
November, 2022 FDA 483 Nissui Corporation - Form 483, 2022-11-11
January, 2020 FDA 483 NuCare Pharmaceuticals,Inc. - Form 483, 2020-01-10
March, 2018 FDA 483 Deseret Laboratories, Inc. - Form 483, 2018-03-23
November, 2022 FDA 483 Eisai Co., Ltd. - Form 483, 2022-11-02
May, 2017 FDA 483 CSBio Co. - Form 483, 2017-05-12
February, 2018 EIR ALS Group USA, Corp. - EIR, 2018-02-16
May, 2019 FDA 483 LUPIN LIMITED - Form 483, 2019-05-15
July, 2019 EIR Shandong Luxi Pharmaceutical Co., Ltd. - EIR, 2019-07-24
July, 2019 FDA 483 Zhuhai United Laboratories Co., Ltd. - Form 483, 2019-07-16
March, 2017 FDA 483 AnazaoHealth Corporation - Form 483, 2017-04-06
January, 2020 EIR Nitto Avecia Pharma Services, Inc. - EIR, 2020-01-24
October, 2017 FDA 483 University Rx Specialist, dba University Compounding Pharmacy - Form 483, 2017-10-27
May, 2017 FDA 483 Meditech Laboratories, Inc - Form 483, 2017-05-11
January, 2019 FDA 483 INDOCO REMEDIES LIMITED - Form 483, 2019-01-25
February, 2018 FDA 483 ALS Group USA, Corp. - Form 483, 2018-02-16
August, 2017 FDA 483 Impax Laboratories, LLC. - Form 483, 2017-08-23
June, 2016 EIR Harmony Foods, LLC. dba SCN BestCo - EIR, 2016-06-09
July, 2019 FDA 483 Shandong Luxi Pharmaceutical Co., Ltd. - Form 483, 2019-07-24
April, 2018 FDA 483 Optum Compounding Services, LLC - Form 483, 2018-04-20
August, 2017 EIR Impax Laboratories, LLC. - EIR, 2017-08-23

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more